Furukawa J, Kakei Y, Murakami S, Kita H, et al. Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial. BMC Cancer 2025;25:195.
PMID: 39905323